Franklin, MA – Prestige Scientific is pleased to announce the successful completion of a Vice President of Pharmacovigilance search for our partner, and internatinal biopharma organization. This critical leadership hire reflects our partner's continued commitment to advancing patient safety and strengthening its global pharmacovigilance capabilities as the company expands its innovative therapeutic portfolio.
In this role, the newly appointed executive will lead the strategic and operational oversight of the company’s global pharmacovigilance function, ensuring the highest standards of drug safety, regulatory compliance, and risk management across all development and commercial programs. They will be responsible for shaping and scaling end-to-end safety systems, driving signal detection and benefit-risk assessment activities, and fostering strong cross-functional collaboration with clinical development, regulatory affairs, and medical teams. A key focus will be enhancing proactive, data-driven safety strategies to support both early-stage innovation and late-stage commercialization.
This individual brings deep expertise in global safety leadership and will play a pivotal role in advancing our partner's mission to deliver transformative therapies to patients with unmet medical needs. Their appointment underscores the importance of pharmacovigilance as a strategic pillar within the organization and positions the organization for continued growth and excellence in patient-centric drug development.
Prestige presented 3 individuals for this role, the hired candidate was presented 12 days from the start of the search, and the search was completed in 39 days. Congratulations to our PV search team for this successful project!
About Prestige Scientific:
Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.
